Credit Suisse Ag Hille Vax, Inc. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
A detailed history of Credit Suisse Ag transactions in Hille Vax, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 15,688 shares of HLVX stock, worth $32,787. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,688
Previous 11,862
32.25%
Holding current value
$32,787
Previous $190,000
36.84%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HLVX
# of Institutions
7Shares Held
4.16MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY2.09MShares$4.37 Million0.0% of portfolio
-
Abingworth LLP London, X01.84MShares$3.84 Million10.2% of portfolio
-
Xtx Topco LTD London, X0179KShares$374,4940.02% of portfolio
-
Tekla Capital Management LLC27KShares$56,4290.02% of portfolio
-
ETF Managers Group, LLC Summit, NJ10.9KShares$22,6910.01% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $69.9M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.